On July 21, an FDA panel discussed the use of selective serotonin reuptake inhibitors during pregnancy. Most panelists misleadingly claimed that all SSRIs are unsafe for pregnant people and their babies, suggesting without evidence that the medications cause autism and miscarriage. Some also falsely claimed that SSRIs do not have any benefits. Experts quoted in articles about the panel debunked some of the panelists’ false claims and correctly noted that untreated depression during pregnancy increases the risk of substance use disorder, preterm birth, preeclampsia, low birth weight, and suicide. Some social media users expressed frustration with the panelists’ misleading claims and several said that taking SSRIs during pregnancy saved their lives. Others falsely claimed that SSRIs are dangerous for everyone, especially pregnant and breastfeeding people and their babies.
Recommendation
In response to common false and misleading claims about SSRIs, communicators may explain that most SSRIs are safe during pregnancy and while breastfeeding and that avoiding or discontinuing SSRIs comes with risks. Messaging may highlight a recent statement from the American College of Obstetricians and Gynecologists noting that untreated depression during pregnancy “can put our patients at risk for substance use, preterm birth, preeclampsia, limited engagement in medical care and self-care, low birth weight, impaired attachment with their infant, and even suicide.” Communicators may also encourage pregnant people to talk to their health care providers about any medications they take, including SSRIs.
